Stockreport

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced the appointment of Lori Kunkel, MD, to its [Read more]